Dopamine neuron morphology and output are differentially controlled by mTORC1 and mTORC2

被引:11
|
作者
Kosillo, Polina [1 ]
Ahmed, Kamran M. [1 ]
Aisenberg, Erin E. [2 ]
Karalis, Vasiliki [1 ]
Roberts, Bradley M. [3 ]
Cragg, Stephanie J. [3 ]
Bateup, Helen S. [1 ,2 ,4 ]
机构
[1] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA
[2] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA
[3] Univ Oxford, Dept Physiol Physiol Anat & Genet, Oxford, England
[4] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA
来源
ELIFE | 2022年 / 11卷
基金
美国国家卫生研究院;
关键词
mTORC1; mTORC2; raptor; rictor; dopamine neurons; TSC; Mouse; COMPLEX; 1; TUBEROUS SCLEROSIS; PARKINSONS-DISEASE; SUBSTANTIA-NIGRA; MAMMALIAN TARGET; BASAL GANGLIA; BRAIN; AKT; RELEASE; RICTOR;
D O I
10.7554/eLife.75398
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The mTOR pathway is an essential regulator of cell growth and metabolism. Midbrain dopamine neurons are particularly sensitive to mTOR signaling status as activation or inhibition of mTOR alters their morphology and physiology. mTOR exists in two distinct multiprotein complexes termed mTORC1 and mTORC2. How each of these complexes affect dopamine neuron properties, and whether they have similar or distinct functions is unknown. Here, we investigated this in mice with dopamine neuron-specific deletion of Rptor or Rictor, which encode obligatory components of mTORC1 or mTORC2, respectively. We find that inhibition of mTORC1 strongly and broadly impacts dopamine neuron structure and function causing somatodendritic and axonal hypotrophy, increased intrinsic excitability, decreased dopamine production, and impaired dopamine release. In contrast, inhibition of mTORC2 has more subtle effects, with selective alterations to the output of ventral tegmental area dopamine neurons. Disruption of both mTOR complexes leads to pronounced deficits in dopamine release demonstrating the importance of balanced mTORC1 and mTORC2 signaling for dopaminergic function.
引用
收藏
页数:43
相关论文
共 50 条
  • [1] mTORC1 and mTORC2 differentially regulate the development of NK cells
    Yang, Chao
    Siebert, Jason
    Thakar, Monica
    Malarkannan, Subramaniam
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [2] Loss of mTORC1 & mTORC2 but nor mTORC1 or mTORC2 leads to reduction in cone function.
    Ma, Shan
    Venkatesh, Aditya
    Punzo, Claudio
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [3] mTORC1 and mTORC2 differentially promote natural killer cell development
    Yang, Chao
    Tsaih, Shirng-Wern
    Lemke, Angela
    Flister, Michael J.
    Thakar, Monica S.
    Malarkannan, Subramaniam
    ELIFE, 2018, 7
  • [4] Novel inhibitors of mTORC1 and mTORC2
    Bhagwat, Shripad V.
    Crew, Andrew P.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2010, 11 (06) : 638 - 645
  • [5] mTORC1 and mTORC2 are differentially engaged in the development of laser-induced CNV
    Yang, Jin Young
    Madrakhimov, Sanjar Batirovich
    Ahn, Dong Hyuck
    Chang, Hun Soo
    Jung, Sang Joon
    Nah, Seung Kwan
    Park, Ha Yan
    Park, Tae Kwann
    CELL COMMUNICATION AND SIGNALING, 2019, 17 (1)
  • [6] mTORC1 and mTORC2 are differentially engaged in the development of laser-induced CNV
    Park, Tae Kwann
    Yang, Jin Young
    Madrakhimov, Sanjar
    Ohn, Young-Hoon
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [7] mTORC1 and mTORC2 in cancer and the tumor microenvironment
    L C Kim
    R S Cook
    J Chen
    Oncogene, 2017, 36 : 2191 - 2201
  • [8] mTORC1 and mTORC2 Levels in Patients with Psoriasis
    Gulsunay, Ilayda Esna
    Altunay, Ilknur
    Kum, Tugba
    Cerman, Asli Aksu
    DERMATOLOGY PRACTICAL & CONCEPTUAL, 2024, 14 (04):
  • [9] mTORC1 and mTORC2 are differentially engaged in the development of laser-induced CNV
    Jin Young Yang
    Sanjar Batirovich Madrakhimov
    Dong Hyuck Ahn
    Hun Soo Chang
    Sang Joon Jung
    Seung Kwan Nah
    Ha Yan Park
    Tae Kwann Park
    Cell Communication and Signaling, 17
  • [10] mTORC1 and mTORC2 in cancer and the tumor microenvironment
    Kim, L. C.
    Cook, R. S.
    Chen, J.
    ONCOGENE, 2017, 36 (16) : 2191 - 2201